December 2025
ProgrammeNivolumab biosimilar pitch deck published
PTC Oncology and technical partner TAC publish the full development and production plan for their lead oncology monoclonal antibody biosimilar programme.
News & Insights
Progress, programmes and perspectives.
A curated view of PTC Oncology's scientific programmes, partnerships and industry insights.
November 2025
PartnershipDeepened collaboration with The Antibody Company
PTC Oncology and TAC formalise their joint approach to UK monoclonal antibody biosimilar development, spanning cell line, formulation and analytics.
September 2025
FacilityOperations continue from Sci-Tech Daresbury
Programmes progress from the CTH Campus at Daresbury Laboratory, one of the UK's leading science and technology campuses.
September 2022
CompanyPTC Oncology founded
Pharmaceutical Technology Centre Limited is established to develop and manufacture oncology monoclonal antibody drugs and support the wider pharmaceutical industry.